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Abstract
Trypanosomes cause disease in humans and livestock throughout sub-Saharan Africa. Although various species show
evidence of clinical tolerance to trypanosomes, until now there has been no evidence of acquired immunity to natural
infections. We discovered a distinct peak and decrease in age prevalence of T. brucei s.l. infection in wild African lions that is
consistent with being driven by an exposure-dependent increase in cross-immunity following infections with the more
genetically diverse species, T. congolense sensu latu. The causative agent of human sleeping sickness, T. brucei rhodesiense,
disappears by 6 years of age apparently in response to cross-immunity from other trypanosomes, including the non-
pathogenic subspecies, T. brucei brucei. These findings may suggest novel pathways for vaccinations against
trypanosomiasis despite the notoriously complex antigenic surface proteins in these parasites.
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Introduction
Trypanosomes transmitted by tsetse flies are a major constraint to
the health and economic development of many of the poorest regions
of Africa. Infections in humans result in over 50,000 deaths each year,
while animal trypanosomiasis is one of the most important livestock
diseases across Africa [1]. The search for effective vaccines to protect
both humans and their livestock populations from the trypanosomi-
ases has proved to be one of the greatest and most elusive challenges
in global public health [1]. This is because of the unique mechanism
of immune invasion employed by the trypanosomes.
Persistence of trypanosome infection depends on evasion of the
host immune response through a complex system of antigenic
variation of the variant surface glycoprotein (VSG) that shields the
cell [2]. Once host antibodies recognize any one VSG, trypano-
somes expressing that VSG are killed. Antigenic variation involves a
stochastic switch in the VSG gene expressed from a repertoire of
possibly a thousand genes; the switching subset of trypanosomes
survives [2]. Although wildlife [3] and cattle [4] show evidence of
clinical tolerance to trypanosomes, until now there has been no
evidence of acquired immunity to natural infections. The absence of
any natural examples of immunity to trypanosomes has been a
major constraint to vaccine development.
Materials and Methods
Study design
184 blood samples were taken from 179 Serengeti lions (Panthera
leo) between 1984 and 1994 as part of long-term ecological and
epidemiological studies [5]. The Serengeti lions have been studied
continuously since 1966; birthdates (accurate to within +/21
month) and annual ranging patterns are known for each individual
in the study. Most samples were collected during genetic surveys
and thus constitute a random sample with respect to health;
additional animals were sampled in 1994 during a veterinary
surveillance program for canine distemper [6], but these
individuals showed no relationship between health and trypano-
somiasis. The lion study area comprised two major habitats: 112 of
the sampled lions (from which 114 samples were taken) lived in
woodlands dominated by Acacia and Commiphora trees; the
remaining 67 lions (from which 70 samples were taken) lived on
open grass plains [7] (Fig. 1). Tsetse flies are largely restricted to
the woodlands, but large numbers of infected herbivores migrate
through both habitats in response to seasonal rainfall.
Laboratory Procedures
Ethical clearance was granted by the Animal Care committee at
the University of Minnesota (reference IACUC 0107A04903), and
heparinized blood was collected from each lion, adhering to the
institution’s guidelines for animal husbandry. Red-cell pellets were
frozen at 280uC. For PCR, the red cell pellet was thawed and
applied to a DNA binding matrix (Whatman FTA). Single 2-mm
blood-saturated discs were cut from the FTA cards to seed each
PCR reaction as previously described [8]. Each sample was
screened three times for the presence of T. congolense s.l. using
primers to repeated internally transcribed sequences [9] and for T.
brucei s.l. using the generic Trypanozoon primers TBR 1 and 2
[10]. Samples that amplified for T. brucei were screened five times
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using primers that amplified the SRA gene specific for human
infective T. b. Rhodesiense [11].
Mathematical models
Two mathematical models based on a standard compartmental,
linked differential equation framework (see [12] pages 58–86) were
fitted to the lion age-prevalence data to examine differences in
infections patterns between the two parasite species (Trypansoma
congolense and T. brucei s.l.) in the contrasting transmission-intensity
habitats (high-intensity woodlands versus low-intensity plains). For
each trypanosome species, both models were fitted to all of the
age-prevalence data combined, as well as separately to the plains
and woodland data. The age categories for the different habitats
are shown in Table 1.
Model 1: Age-constant force of infection and
recovery. The simplest model assumed susceptible lions (S)
were infected at a rate l, generally referred to as the force of
infection which is the per capita rate at which susceptibles acquire
infection (see [12] page 51). It was further assumed that l was
independent of age (a) and infected lions (I) recovered from infection
at a rate n, upon which they reverted to the susceptible status.
This can be expressed as a set of linked differential equations as
dS
da
~{lSzuI ð1Þ
and
dI
da
~lS{uI : ð2Þ
In this model system, 1/l is the average age of first infection and
1/n is the average duration of infection.
This model formed the baseline against which the more
complicated model incorporating an immune class was compared.
Model 2: Immune class. Model 1 was extended by the
introduction of an immune class (R) following recovery from
infection. Immunity was lost at a rate c (giving an average duration
of immunity from infection of 1/c) with lions reverting to the
susceptible status immediately following the loss of immunity.
The linked equations describing the model are:
dS
da
~{lSzcR, ðS3Þ
dI
da
~lS{uI , ðS4Þ
and
dR
da
~uI{cR: ðS5Þ
All models were fitted to the observed data using standard non-
linear maximum likelihood techniques assuming binomial error
Figure 1. Map of the 2,000 km2 Serengeti study area. Map
colours indicate habitat: woodlands (dark green), tall-grass plains (olive),
intermediate grass plains (pale green) and short grass plains (bright
green). Pie-charts show the proportion (in blue) of animals infected with
either T. congolense or T. brucei; size of each chart is proportional to the
number of lions sampled in each pride; each chart is centred at the
approximate midpoint of each pride’s territory.
doi:10.1371/journal.pntd.0000347.g001
Author Summary
Trypanosomiasis is a major health threat in Africa, but
vaccine development has long been hampered by the
extraordinarily diverse surface proteins of these parasites.
However, Serengeti lions show an asymptotic age
prevalence of the non-pathogenic Trypanosoma congo-
lense in contrast to a strong peak and decrease in age
prevalence of the pathogenic T. brucei s.l.. This pattern
suggests that lions may gain cross-immunity to T. brucei
from repeated exposure to the more genetically diverse T.
congolense. Although lions may gain more effective cross
immunity than other host species owing to their frequent
consumption of infected prey animals, these findings
suggest possible strategies for designing effective vaccines
against sleeping sickness in livestock and humans.
Table 1. Details of the age groups used in the mathematical models.
Woodlands Plains All
Average age, years Number of samples Average age, years Number of samples Average age, years Number of samples
1.1 22 1.5 14 1.1 26
2.0 22 2.7 14 1.8 26
3.5 22 5.5 14 2.5 26
6.8 22 8.7 14 4.2 26
10.7 26 11.6 14 6.9 26
8.7 26
12.0 28
Total 114 70 184
doi:10.1371/journal.pntd.0000347.t001
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structure [13]. We tested the statistical significance of moving from
the simpler Model 1 to the more complicated Model 2 by
comparing the difference in ln-maximum likelihood to the x2
distribution [13]. Model fitting was conducted in Excel.
Survival analysis to examine differences in mortality rates
between lions with different trypanosome infection status was
conducted using a Cox proportional hazard model with censoring
for the six individuals yet to die and controlling for the birth year.
The analysis was conducted in Stata.
Results
The lions show a distinct peak in age prevalence for T. brucei s.l.,
a pattern which was maintained when the data was examined
separately for both the plains and woodland habitats, but the
pattern in T. brucei s.l. age prevalence is statistically more
pronounced in woodlands lions living under higher tsetse
challenge (Fig. 2B). By contrast, T. congolense s.l. infection
consistently shows a monotonic increase with age (Fig. 2A, B
and C).
The strong peak in prevalence for T. brucei s.l. at 2–3 yrs of age
is not due to increased mortality in infected animals, since there
was no significant difference in the survival schedules of
trypanosome-positive and -negative individuals (Fig. 3). Alterna-
tively, infections would be expected to decline with age with the
development of acquired immunity. Using the parameters in
Table 2, the simple two-compartment Model 1 was first fitted to
the T. congolense data, and we then tested whether the addition of
some form of temporary protective immunity (Model 2) would
significantly improve the fit of the model. For T. congolense, Model 1
could not be significantly improved by adopting Model 2 for all
the data combined (x2 = 0.850, d.f. = 1, P=0.357) as well as the
woodlands (x2 = 0.585, d.f. = 1, P=0.444) and plains (x2 = 0.083,
d.f. = 1, P=0.773) data analysed separately (Fig 2A, B and C).
We then tested whether the T. brucei data could be better
explained by an acquired immunity that resulted in the
establishment of a temporary immune class before reversion to
the susceptible class. In contrast to T. congolense, inclusion of
temporary protective immunity resulted in a statistically significant
improvement (x2 = 5.536, d.f. = 1, P=0.019) over the simpler
Model 1, when all the T. brucei s.l. data were analysed together
(Fig. 2A). For both woodlands and plains T. brucei data, the
inclusion of temporary immunity improved the fit of the model
better captured the distinct pattern of intermediate peak and
subsequent drop in prevalence with age. Importantly, however,
the inclusion of temporary immunity in Model 2 was only
statistically significant in the high-transmission woodlands
(x2 = 7.537, d.f. = 1, P=0.0.30), but not in the low-transmission
plains habitat (x2 = 1.079, d.f. = 1, P=0.299).
None of the T. b. brucei-infected samples from lions over 6 yrs of
age (n = 21) were co-infected with T. b. rhodesiense compared to
18% of T. b. brucei-infected lions younger than 6 yrs (n = 50,
P= 0.050, Fisher exact 2-tailed test), suggesting that older lions
control T. b. rhodesiense infection more effectively than younger
Figure 2. Model fitted to T. brucei and T. congolense age-prevalence curves in (A) all Serengeti lions, those living in (B) the high
tsetse-exposure woodlands and (C) the low tsetse-exposure plains. For the combined data and in both habitats analysed separately, the
simple Model 1 assuming a constant force and duration of infection were fitted to the T. congolense data and could not be significantly improved by
including an immune class. For T. brucei, the illustrated model for all three data sets includes a temporary immune class that significantly improves
the fit to the data compared to a Model 1 in panels (A) and (B) but was not statistically significant in (C).
doi:10.1371/journal.pntd.0000347.g002
Figure 3. Kaplan-Meier survival curves for Serengeti lions. There was no significant difference in the survival schedules (x2 = 6.76, d.f. = 3,
p.0.05, Cox proportional hazard model with censoring for the six individuals yet to die and controlling for the birth year) for lions without any
trypanosome infections (median survival time= 9.59 years, 95% CIs 5.79–10.93 years), those infected with T. brucei only (10.84, 95% CIs 7.52–12.64),
those infected with T. congolense only (9.47, 8.61–10.28), and those infected with both species (10.32, 3.54–11.53).
doi:10.1371/journal.pntd.0000347.g003
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lions. In the susceptible age group (,6 yrs), 27.8% of plains lions
infected with T. b. brucei were co-infected with T. b. rhodesiense,
which is very similar to the 1:3 ratio of prevalence of T.b. rhodesiense
to that of T. b. brucei consistently observed in all other host species
in which the two subspecies co-exist [14]. However, only 12.5% of
the T.b. brucei-infected woodlands lions were co-infected with T. b.
rhodesiense, giving a ratio of only 1:7, and implying that lions
subjected to a higher force of infection by T.b. brucei are more likely
to control T. b. rhodesiense infections.
Discussion
These findings are the first epidemiological evidence consistent
with the development of acquired immunity to trypanosomes in
any host species. It is unlikely that some hitherto unknown aspect
of innate immunity is responsible for the peak and drop in age-
prevalence, because this pattern is only seen in T. brucei and not T
congolense. Instead, our observations are consistent with acquired
immunity being mounted against T. brucei, and several aspects of
lion ecology make them ideal candidates for acquired immunity.
First, the Serengeti lions are co-infected with multiple species of
trypanosomes: besides T. congolense (Savannah), T. brucei and T. b.
rhodesiense, lions are also exposed to T. congolense (Kilifi and Tsavo),
T. vivax and T. simiae. Trypanosomes switch the variable surface
glycoproteins (VSGs) on their surface coats every 3–5 days to
avoid immune recognition by the host [15]. Thus on any given
day, 6–15 different VSG populations circulate in an infected
individual with associated increases in antibody levels [14]. The
immune system of a co-infected host is inevitably exposed to a
greater variety of VSGs, thus the entire VSG repertoire would be
exhausted more quickly if haplotypes were shared across species.
The VSG repertoires in the different species and strains circulating
within the Serengeti ecosystem are likely to contain many common
VSG genes. T. congolense s.l. shows far more genetic variability than
T. brucei s.l. [16], suggesting that the range of naturally expressed
VSGs is also higher in T. congolense s.l.. T. brucei, may in turn
generate more variable VSGs than T. brucei rhodesiense due to the
SRA gene which allows T. brucei rhodesiense to avoid lysis in the host
bloodstream but which is localised to a single active VSG
expression site [17]. Thus, continued high exposure to and
increasing infection with T. congolense s.l. allows the lions to clear
most infections of T. brucei s.l. by 3–5 yrs of age and to eliminate all
infections of T. brucei rhodesiense by the age of 6 yrs. Frequent re-
exposure to each trypanosome species by tsetse bites should also
accelerate the onset and extent of immunity, thus prevalence
should be lowest in areas of high-tsetse exposure (as clearly seen in
Fig. 2 for T. brucei in the woodlands lions compared to the plains
lions, and also the lower ratio of T. brucei rhodesiense to T. brucei brucei
in the woodlands).
Second, carnivores are exposed to trypanosomes through
multiple pathways. The plains lions had a similar force of infection
for T. brucei s.l. as did the woodlands lions, suggesting that
infections must also have been acquired by consuming infected
meat (since they were exposed to so few tsetse flies). Flesh from
infected prey animals would have exposed the lions to as many as
3400 bloodstream-form VSGs in only two years, potentially
compromising the predicted repertoire for T. brucei [18–19]. Thus
the acquisition of immunity may be accelerated in any carnivorous
host species, but further work will be needed to determine if
carnivores generally acquire immunity at younger ages than wild
herbivores.
Demonstration of natural immunity is essential if we are to fully
understand the epidemiology of human and animal trypanosomi-
asis and ultimately provide an empirical basis for vaccine
development. Recent studies in T. brucei have shown that the
location of divergence between VSGs is consistent with selection
for strain-specific VSG repertoires with the consequence that any
vaccine based on large numbers of VSGs from a single strain may
only provide partial protection against other strains [20], but such
partial protection may be sufficient under natural circumstances to
protect animals from harboring human infective T. b. rhodesiense. In
regions such as E Uganda where cattle act a major reservoir of
human infection vaccination would invaluable. Until now,
trypanosome researchers have been convinced that immunity is
impossible and, hence, that vaccines would be impracticable, but
the clear evidence of acquired immunity in lions for T. brucei s.l.
generates an entirely new perspective on existing data and future
research in this field.
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